Pharmacokinetics and Point of Care Testing of Direct Oral Anticoagulants Subjects

NCT05491460 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Anticoagulant Therapy

Interventions

DRUG: Apixaban 5 MG Tab
DRUG: Dabigatran 150 MG Tab
DRUG: Edoxaban 60Mg Tab
DRUG: Rivaroxaban 20 MG Tab

Sponsor

Doasense GmbH